LEADER 06067nam 22004695 450 001 9910337509303321 005 20200705101717.0 010 $a3-030-03140-3 024 7 $a10.1007/978-3-030-03140-4 035 $a(CKB)4100000007810335 035 $a(MiAaPQ)EBC5735512 035 $a(DE-He213)978-3-030-03140-4 035 $a(PPN)235231509 035 $a(EXLCZ)994100000007810335 100 $a20190319d2019 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPosterior Uveitis $eAdvances in Imaging and Treatment /$fedited by Narsing A. Rao, Julie Schallhorn, Damien C. Rodger 205 $a1st ed. 2019. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019. 215 $a1 online resource (231 pages) 225 1 $aEssentials in Ophthalmology,$x1612-3212 311 $a3-030-03139-X 327 $aA. Introduction -- 1. Current imaging modalities in Diagnosis and Management of Intraocular Inflammation -- Phillip Phuc Le (Anterior segment OCT, OCT imaging of Retina, OCT-EDI imaging of Retina and Choroid, Wide field fluorescein and ICG angiography, Auto-fluorescence, OCT angiography and Evolving imaging modalities).-B. Non-Infectious Posterior and Pan Uveitis -- 2. Sarcoidosis: Padmamalini Mahendradas (Introduction, main clinical features, differential diagnosis and treatment, wide field color fundus photo, fluorescein angiography and ICG angiography, OCT, Autofluorescence, Evolving imaging modalities (e.g. OCT angiography and others), Response to treatment imaging) 3. Vogt-Koyanagi-Harada disease and Sympathetic Ophthalmia: Jeffrey J. Tan and Narsing -- Rao (Introduction, main clinical, features, differential diagnosis and treatment, Wide field color fundus photo, fluorescein angiography and ICG angiography, OCT, Autofluorescence, Evolving imaging modalities (e.g. OCT angiography and others), Response to treatment imaging) -- 4. Multifocal Choroiditis/ Serpiginous Choroiditis and related entities: Hossein Nazari -- Khanamiri and Narsing Rao (Introduction, clinical features, differential diagnosis and treatment, Wide field color fundus photo, fluorescein angiography and ICG angiography, OCT, Autofluorescence, Evolving imaging modalities (e.g. OCT angiography and others), Response to treatment imaging